top
mobile menu button
 
A+ -A Français Make a Payment
Search Arrow

Partner Updates- Services

  • Changes to Cryoglobulin and Cryofibrinogen Test Requests
  • New Test Codes for Ordering Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis Effective June 23, 2025 - (QC Only)
  • Change to Insulin Collection Instructions - (ON Only)
  • Important Update re. Postal Service Disruption
  • Change to Bioavailable Testosterone testing - (BC Only)
  • Change to Insulin Collection Instructions - (ON Only)
  • Kidney function laboratory test reporting updates in Quebec - (QC Only)
  • Update to serum lithium therapeutic range
  • Change to Blood Collection Tubes for Steroid Hormones
  • Update to chemical and microscopic urinalysis instrumentation - (ON Only)
  • Change to hepatitis serology and Lp(a) testing - (BC Only)
  • Changes to Trace Element Testing
  • Process Update: ordering tests for sexually transmitted infection (STI) during a cervical screening visit - (ON Only)
  • Ontario and Manitoba: Change to Blood Collection Tubes - (ON and MB Only)
  • Important Update re. Postal Service Disruption for Ontario Clients - (ON Only)
  • Important Update re. Postal Service Disruption
  • Change to Hereditary Cancer Screening Service
  • Process Update: Addition of Primary Human Papillomavirus Testing with Reflex Cytology for Quebec Clients - (QC Only)
  • Changes to STAT Urine Stick and STAT Urine Pregnancy onsite testing at Manitoba Laboratory Health Service Centres - (MB Only)
  • Dynacare Manitoba Semen Analysis - (MB Only)
  • Summary of Test Utilization Management Initiatives in 2023 - (ON Only)
  • Change to Insulin test ordering - (BC Only)
  • Changes to Ferritin Reference Intervals - (ON, QC & MB Only)
  • Update to HIV Nucleic Acid Amplification Testing Confirmation for Insurance Clients
  • Changes to Occult Blood Testing – ON Only
  • Change to Routine Chemistry and Immunoassay Testing Platform - (BC Only)
  • Changes to Immunohematology Testing
  • Centralization of CBC testing in the Okanagan - (BC only)
  • Update from Dynacare Genetics and Specialty Services: New Shipping Label for “Exempt Human Specimen”
  • Discontinuation of Post-vasectomy testing: Penticton - Ellis St. Laboratory and Health Services Centre
  • Changes to Lupus Anticoagulant Testing - (ON & QC only)
  • Update to Serum Amyloid A (SAA) Testing: Collection now Available in Dynacare LHSCs in Ontario and Quebec
  • Discontinuation of Prenatest® Prenatal Screening Test (QC only)
  • Changes to Trace Element Testing
  • Kidney function laboratory test reporting updates in Ontario
  • Mid Steam Urine Sample Collection, Procedure Change - (MB only)
  • Genecept Assay® Name Change and Improved Features
  • Laboratory Developed Tests
  • Changes to acetylcholine receptor antibody, leptin and insulin antibody testing
  • Dynacare Forensic Toxicology Lab in London earns ISO 17025 Accreditation
  • Manitoba lipid reporting update
  • Testing Update: Implementation of Infectious Diarrhea Panel and FecalSwab Collection Devices for Detection of Enteric Pathogens - (BC only)
  • Testing Update: Standardization of Fungal Culture and Microscopy Requests
  • Resumption of Urine Oxalate Testing
  • Change to Collection Tube Requirement for Complete Blood Count and Hemoglobin A1c - (ON Only)
  • Change to Blood Collection Tubes, Devices and Needles - (ON & MB)
  • Testing Update: Nucleic Acid Amplification Test (NAAT) and Culture Co- testing Requests for Neisseria gonorrhoeae - (ON Only)
  • Interpretation Guide: Immunoassay-based Urine Drug Screening
  • Resumption of Microbiology Culture Services - Dobrin Laboratory
  • Quebec: Discontinuation of ANCA Indirect Immunofluorescence
  • Ontario: Changes to Community-Based Funding of anti-CCP and ANCA and Discontinuation of ANCA Indirect Immunofluorescence
  • Resumption of additional services for Microbiology Culture Services - Dobrin (QC Only)
  • Temporary Suspension of Urine Oxalate Testing
  • Testing Update: Modification to Reporting Colony Counts for Urine Culture - (MB Only)
  • Update on Resumption of Microbiology Culture Services - Dobrin (QC Only)
  • Food IgG Antibody Test Report is Now Available to Patients on Dynacare Plus
  • Update – Resumption of additional services for Microbiology Culture Services - Dobrin (QC Only)
  • Changes to Trace Element (Metal) Testing
  • Dynacare Manitoba: Introduction of automated detection of hemolyzed, icteric, and lipemic samples - (MB Only)
  • Summary of 2022 test utilization management initiatives - (ON Only)
  • Partial Service Level Resumption for Microbiology Culture Services - Dobrin (QC Only)
  • Discontinuation of RBC cholinesterase testing and change in serum cholinesterase testing
  • Testing Update: Antimicrobial Susceptibility Testing (AST) Process Change for Perinatal Group B Streptococcus (GBS) - (BC Only)
  • Temporary Slowdown impacting Turnaround Times and Reduced Service Times in the Microbiology Culture Services - Dobrin (QC Only)
  • Change in Methodology for Anti-Epileptic Drug Testing: Phenobarbital, Primidone, and Ethosuximide (ON & QC)
  • Changes to Food IgG Test Report
  • Lipid reporting update - (ON Only)
  • Sample collection for ThinPrep® Pap Test - (ON only)
  • Change to Vedolizumab Testing
  • Update to Myeloproliferative Disorder Testing: Launch of MPL Testing Effective November 1st, 2022
  • Discontinuation of Herpes Simplex Virus (HSV) Testing - Ontario and Quebec
  • Service Update: Transition of Wet Mount to Molecular Testing for the Routine Diagnosis of Trichomonas vaginalis Infection
  • Service Update: Expanded Test Menu for Chlamydia, Gonorrhea and Trichomonas Testing
  • Changes to Urine Broad Spectrum Toxicology Panel Test
  • Semen Analysis Testing Update in London - (ON Only)
  • Discontinuation of anti-sperm and anti-ovary antibody testing in Ontario and Quebec
  • OAML - Community Laboratory Service Update: Monkeypox Testing
  • Summary of 2021 Test Utilization Management Initiatives - Ontario
  • QuantiFERON®-TB Gold Plus Testing Platform Change
  • Temporary change to testing: 17-hydroxyprogesterone and androstenedione Ontario & Quebec
  • Service Update: Use of Swab Collection Devices for Routine Microbial Analysis at Dynacare Manitoba Laboratory and Health Services Centres
  • Service Update: Human Papillomavirus Testing Platform Change for Manitoba Private Clients
  • Review of Equation for Estimated Glomerular Filtration Rate (eGFR)
  • Do your patients need COVID-19 testing before travelling outside of Canada?
  • Resumption of Breath Collections at Dynacare Laboratory and Health Services Centres - Ontario Only
  • Change to testing: Islet cell antibody and skin antibodies (pemphigus and pemphigoid)
  • OAML communication re. Shortage of Medical Supplies. Ontario only
  • Dynacare Introduces Clostridioides (Clostridium) difficile Fecal Testing - Ontario Only
  • Service Update: Chlamydia trachomatis and Neisseria gonorrhea - Nucleic Acid Amplification Testing - Updated Process for Sample Intake
  • Update to Myeloproliferative Disorder Testing: Launch of CALR Testing and Simplification of Test Ordering for JAK2 and BCR-ABL Effective March 14th, 2022
  • Migration of testing: Anti-Glomerular Basement Membrane and Anti-Centromere
  • Urgent Chemistry Testing Services (Southwestern ON Only)
  • Changes to Serum Dihydrotestosterone and Estrone Testing
  • Temporary Suspension of Breath Collections at Dynacare Laboratory and Health Services Centres
  • Service Update: Discontinuation of Wet Mount for the Routine Diagnosis of Trichomonas vaginalis Infection
  • Testing Update: SARS-CoV-2 Variant of Concern Screening and Impact on COVID-19 Diagnostic Molecular Testing Performance
  • Changes to Serum 17-Hydroxyprogesterone and Androstenedione Testing
  • Service Update: Discontinuation of Tuberculosis Culture (Ontario Only)
  • Changes to Celiac Tests, Apolipoprotein B, Lipoprotein a, and NT-proBNP in Ontario
  • The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC)